Gao J, Qiu H, Tong Y, Huang C, et al. Venetoclax-enhanced reduced-intensity conditioning in older patients aged >/=55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study. Br J Haematol 2026;209:1773-1782.
PMID: 42457583